As in the other AWARD trials, most of the reduction in body weight and fasting plasma glucose in dulaglutide-treated patients occurred in the first 2 weeks of treatment
Research priorities include fully characterizing GLP-3s mechanisms and receptor interactions, establishing optimal dosing and administration protocols, conducting larger-scale clinical trials for various metabolic conditions, exploring combination approaches with GLP-1 and other interventions, and identifying patient populations most likely to benefit
In a Phase 3 randomized controlled trial, researchers at Fudan University and Hangzhou Sciwind Biosciences in China discovered that ecnoglutide it works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels
Researchers investigate interactions with biological pathways involved in energy signaling, metabolic regulation, and recovery processes
Consistency of the chosen day and time matters more than the specific hour, in line with NHS guidance for comparable weekly injectables
